Cardinal Health Enters into Binding Letter of Intent to Extend Pharmaceutical Distribution Agreements with CVS Health
PR Newswire•01/10/2026•06:50 ET
0
Key Highlights
- ➤CVS Health distribution agreement extended through June 30, 2032
- ➤Cardinal Health (CAH) reaffirmed fiscal 2027 non-GAAP EPS growth guidance of 13% to 15%
- ➤Fiscal 2027 non-GAAP EPS guidance reaffirmed at $12.40 to $12.60
- ➤Long-term non-GAAP EPS growth guidance reaffirmed at 12% to 14%
Expert Statements
Jason Hollar, CEO of Cardinal Health
“We value our long-standing partnership with CVS Health and look forward to continuing to bring our best-in-class capabilities together to serve their customers”
Cardinal Health Enters into Binding Letter of Intent to Extend Pharmaceutical Distribution Agreements with CVS Health PR Newswire
DUBLIN, Ohio, Oct. 1, 2026 /PRNewswire/ -- Cardinal Health (NYSE: CAH) announced today that it has entered into a binding Letter of Intent to extend its existing distribution agreement with CVS Health through June 30, 2032, reflecting the continuation of Cardinal Health's current scope of distribution services.
Get started
Create a free account to read the full story.